QTERN

saxagliptin and dapagliflozin · AstraZeneca

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for QTERN, covering 2025-03-06 to 2026-06-11. Get the full timeline:

Most recent: EMA Authorised: Qtern (saxagliptin;dapagliflozin propanediol monohydrate) — Astra Zeneca AB